510(k) Report

510(k) · Cleared

Cleared

Fox Plus Pta Catheter

K040954510(k) SpecialCleared May 11, 200428-day reviewClass II21 CFR 870.1250

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Abbott Laboratories, Inc. · LIT Catheter, Angioplasty, Peripheral, Transluminal

Cleared on May 11, 2004 as substantially equivalent to K020854 (Jomed AG, 2002) after a 28-day review. Its family tree reaches back 2 generations to 2000. 5 later devices descend from it.

Decided
May 11, 2004
Review
28 days
Class
Class II
Product code
LIT
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to K000101 (2000). 4 ancestors in all. 5 later devices descend from it, 2 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 2001: 2 other ancestors2008: 2 descendants cleared2005: 1 descendant cleared2006: 1 descendant cleared2007: 1 descendant clearedK000101 · RX Viatrac 14 Peripheral Dilatation Catheter · Guidant Corp. · 2000K020854 · Modification to Fox Pta Catheter · Jomed AG · 2002200020052010201520202025
Other ancestors, by generationDescendants, by generation 2 generations back: 2 other ancestors 1 generation forward: 2 descendants2 generations forward: 2 descendants3 generations forward: 1 descendant K020854 · Modification to Fox Pta Catheter · Jomed AG · 2002K000101 · RX Viatrac 14 Peripheral Dilatation Catheter · Guidant Corp. · 20000
  1. Root · 2 generations backK000101 RX Viatrac 14 Peripheral Dilatation CatheterGuidant Corp. · 2000
  2. 1 generation backK020854 Modification to Fox Pta CatheterJomed AG · 2002
  3. This deviceK040954 Fox Plus Pta CatheterAbbott Laboratories, Inc. · 2004
  4. Descendant · cites it directly · 2 of its ownK051519 Fox SV Pta Catheter (82XXX Series). Fox Plus Pta Catheter (12XXX…Abbott Laboratories (Perclose, Inc.) · 2005
  5. Descendant · cites it directly · 1 of its ownK080264 Modification to: Fox Plus Pta CatheterAbbott Vascular-Vascular Solutions · 2008
  6. Descendant · 2 generations on · 1 of its ownK062843 Fox SV Pta CatheterAbbott Laboratories · 2006
  7. Descendant · 2 generations on · 0 of its ownK080925 Fox Plus Pta CatheterAbbott Vascular, Inc. · 2008
  8. Descendant · 3 generations on · 0 of its ownK072824 Fox SV Pta CatheterAbbott Laboratories · 2007

Most influential descendants

Showing 5 of 5 · See all
  • K051519Fox SV Pta Catheter (82XXX Series). Fox Plus Pta Catheter (12XXX Series)Abbott Laboratories (Perclose, Inc.) · 2005 · cites it directly2descendants
  • K080264Modification to: Fox Plus Pta CatheterAbbott Vascular-Vascular Solutions · 2008 · cites it directly1descendant
  • K062843Fox SV Pta CatheterAbbott Laboratories · 2006 · 2 generations on1descendant
  • K080925Fox Plus Pta CatheterAbbott Vascular, Inc. · 2008 · 2 generations on0descendants
  • K072824Fox SV Pta CatheterAbbott Laboratories · 2007 · 3 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K000101RX Viatrac 14 Peripheral Dilatation CatheterGuidant Corp.2000—
−1K020854Modification to Fox Pta CatheterJomed AG2002—
0 (this device)K040954Fox Plus Pta CatheterAbbott Laboratories, Inc.2004—
+1K051519Fox SV Pta Catheter (82XXX Series). Fox Plus Pta Catheter (12XXX Series)Abbott Laboratories (Perclose, Inc.)2005—
+1K080264Modification to: Fox Plus Pta CatheterAbbott Vascular-Vascular Solutions2008—
+2K062843Fox SV Pta CatheterAbbott Laboratories2006—
+2K080925Fox Plus Pta CatheterAbbott Vascular, Inc.2008—
+3K072824Fox SV Pta CatheterAbbott Laboratories2007—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200120

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200510
200610
200710
200820
FIG. 1 — Lineage of K040954, 2000–2008Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LIT? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LIT device

  1. #1 K241040 Amethyst HP PTA OTW 0.035 Catheterscore 13.9 · 9 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K020854Modification to Fox Pta Catheter
Summary page 1
…21 CFR 870.1250 Classification Name: Percutaneous Transluminal Angioplasty Catheter Product Code: LIT Predicate Device: Fox PTA Catheter (K020854) Intended Use: The Fox Plus PTA Catheter is intended for dilatation of lesions in the fe…
Jomed AG2002—

Also cleared against K020854: 2 other devices →

What descends from it? (5)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K051519Fox SV Pta Catheter (82XXX Series). Fox Plus Pta Catheter (12XXX Series)Abbott Laboratories (Perclose, Inc.)20052
K080264Modification to: Fox Plus Pta CatheterAbbott Vascular-Vascular Solutions20081

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 4 years and passes through 3 companies; a new generation was cleared every 2.2 years on median.
  • None of the 4 ancestors has a recall.
  • Of its descendants, K051519 (Abbott Laboratories (Perclose, Inc.), 2005) has gone furthest, with 2 descendants of its own.
  • 2 other devices also cite its predicate K020854.

How does its category compare?

All LIT devices

LIT Catheter, Angioplasty, Peripheral, Transluminal: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · LIT

3in 2025

2007: 62008: 82009: 72010: 132011: 102012: 192013: 142014: 122015: 192016: 112017: 92018: 62019: 42020: 92021: 42022: 82023: 62024: 62025: 32026 (partial year): 4
2007high 19 (2012) · low 3 (2025)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LIT

90in 2025

2007: 64 days median2008: 53 days median2009: 29 days median2010: 78 days median2011: 82 days median2012: 29 days median2013: 79 days median2014: 90 days median2015: 112 days median2016: 116 days median2017: 57 days median2018: 118 days median2019: 40 days median2020: 125 days median2021: 61 days median2022: 122 days median2023: 167 days median2024: 43 days median2025: 90 days median2026 (partial year): 205 days median
2007high 205 (2026) · low 29 (2009)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LIT

1in 2025

2009: 22010: 12013: 2, 2 Class I2014: 32016: 12018: 22019: 32021: 12024: 22025: 1
2007high 3 (2014) · low 0 (2007)2026

Class I (2 since 2007) Class II/III not classified

Adverse event reports per year · LIT

2,073in 2025

2007: 5772008: 5132009: 6232010: 8092011: 8572012: 1,2772013: 1,2422014: 1,1782015: 1,2792016: 1,5292017: 2,0812018: 2,1882019: 2,4052020: 2,4432021: 2,4922022: 2,1552023: 1,8072024: 1,9132025: 2,073
2007high 2,492 (2021) · low 513 (2008)2025

MAUDE reports naming product code LIT, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20076640577
20088530513
20097292623
201013781809
201110820857
2012192901,277
201314792 (2)1,242
2014129031,178
20151911201,279
20161111611,529
201795702,081
2018611822,188
201944032,405
2020912502,443
202146112,492
2022812202,155
2023616701,807
202464321,913
202539012,073
202642050—

What is it indicated for?

The Fox Plus PTA Catheter is intended for dilatation of lesions in the femoral, renal, iliac, popliteal, peroneal, and profunda arteries and native or synthetic arteriovenous dialysis fistulae.

This catheter is not intended for the expansion or delivery of stents.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K040954: Fox Plus Pta Catheter.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 3, 2026. https://510kreport.com/device/K040954

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026